Sysmex Corporation (SSMXF)
- Previous Close
15.95 - Open
15.95 - Bid --
- Ask --
- Day's Range
15.95 - 15.95 - 52 Week Range
15.95 - 55.56 - Volume
36 - Avg. Volume
482 - Market Cap (intraday)
10.179B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
34.67 - EPS (TTM)
0.46 - Earnings Date --
- Forward Dividend & Yield 0.19 (1.16%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
--
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
www.sysmex.co.jpRelated News
Performance Overview: SSMXF
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SSMXF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SSMXF
Valuation Measures
Market Cap
10.18B
Enterprise Value
10.11B
Trailing P/E
34.38
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.54
Price/Book (mrq)
3.79
Enterprise Value/Revenue
0.02
Enterprise Value/EBITDA
0.10
Financial Highlights
Profitability and Income Statement
Profit Margin
10.28%
Return on Assets (ttm)
8.80%
Return on Equity (ttm)
11.55%
Revenue (ttm)
438.28B
Net Income Avi to Common (ttm)
45.06B
Diluted EPS (ttm)
0.46
Balance Sheet and Cash Flow
Total Cash (mrq)
60.69B
Total Debt/Equity (mrq)
12.30%
Levered Free Cash Flow (ttm)
4.34B
Company Insights: SSMXF
SSMXF does not have Company Insights